AdAlta secures A$1.28 million in rights offer to advance AD-214 | News Direct

AdAlta secures A$1.28 million in rights offer to advance AD-214

AdAlta Ltd
News release by AdAlta Ltd

facebook icon linkedin icon twitter icon pinterest icon email icon Melbourne, Victoria | May 25, 2023 10:30 AM Eastern Daylight Time

AdAlta Ltd (ASX:1AD) managing director Dr Tim Oldham tells Proactive the company’s rights offer has raised A$1.28 million before costs, with commitments in hand to achieve the balance of the A$3.15 million target. The proceeds will help fund the early return to the clinic for lead asset AD-214 as well as progress partnering discussions.

 

 

Contact Details

 

Proactive Investors

 

Jonathan Jackson

 

+61 413 713 744

 

jonathan@proactiveinvestors.com

project media

Tags

AdAlta LtdAsxproactiveAustraliaproactiveInvestorsbiotech